Author + information
- Received March 3, 1995
- Revision received April 12, 1996
- Accepted June 11, 1996
- Published online November 1, 1996.
- William J. Stephan, MD,
- James H. O'Keefe Jr., MD, FACC**,
- Jeffrey M. Piehler, MD, FACC,
- Ben D. McCallister, MD, FACC,
- Rajiv S. Dahiya, MD,
- Thomas M. Shimshak, MD, FACC,
- Robert W. Ligon, MS and
- Geoffrey O. Hartzler, MD, FACC
- ↵**Address for correspondence: Dr. James H. O'Keefe. Jr., Cardiovascular Consultants, Inc., 4330 Wornall Road, Suite 2000. Kansas City, Missouri 64111.
Objectives. We attempted to determine the relative risks and benefits of percutaneous transluminal coronary angioplasty (PTCA) and repeat coronary artery bypass grafting (re-CABG) in patients with previous coronary bypass surgery (CABG).
Background. Due to an expanding population of patients with surgically treated coronary artery disease and the natural progression of atherosclerosis, an increasing number of patients with previous CABG require repeat revascularization procedures. Although there are randomized comparative data for CABG versus medical therapy and, more recently, versus PTCA, these studies have excluded patients with previous CABG.
Methods. We retrospectively analyzed data from 632 patients with previous CABG who required either elective re-CABG (n = 164) or PTCA (n = 468) at a single center during 1987 through 1988. The PTCA and re-CABG groups were similar with respect to gender (83% vs. 85% male), age >70 years (21% vs. 23%), mean left ventricular ejection fraction (46% vs. 48%), presence of class III or IV angina (70% vs. 63%) and three-vessel coronary artery disease (77% vs. 74%).
Results. Complete revascularization was achieved in 38% of patients with PTCA and 92% of those with re-CABG (p < 0.0001). The in-hospital complication rates were significantly lower in the PTCA group: death (0.3% vs. 7.3%, p < 0.0001) and Q wave myocardial infarction (MI) (0.9% vs. 6.1%, p < 0.0001). Actuarial survival was equivalent at 1 year (PTCA 95% vs. re-CABG 91%) and 6 years (PTCA 74% vs. re-CABG 73%) of follow-up (p = 0.32). Both procedures resulted in equivalent event-free survival (freedom from death or Q wave MI) and relief of angina; however, the need for repeat percutaneous or surgical revascularization, or both, by 6 years was significantly higher in the PTCA group (PTCA 64% vs. re-CABG 8%, p < 0.0001). Multivariate analysis identified age >70 years, left ventricular ejection fraction <40%, unstable angina, number of diseased vessels and diabetes mellitus as independent correlates of mortality for the entire group.
Conclusions. In this nonrandomized series of patients with previous CABG requiring revascularization, an initial stategy of either PTCA or re-CABG resulted in equivalent overall survival, event-free survival and relief of angina. PTCA offers lower procedural morbidity and mortality risks, although it is associated with less complete revascularization and a greater need for subsequent revascularization procedures.
This work was presented in part at the 67th Annual Scientific Sessions of the American Heart Association, Dallas, Texas, November 1994.
- Received March 3, 1995.
- Revision received April 12, 1996.
- Accepted June 11, 1996.
- American College of Cardiology